Improved Specificity of Glutamate Decarboxylase 65 Autoantibody Measurement Using Luciferase-Based Immunoprecipitation System Assays
Diabetes · 01.04.2024 · 73 (4) · 565-571
DOI: 10.2337/db23-0550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 17.01.2024. Verfasst von Rebecca C Wyatt und 13 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Metabolism Unit, Translational Health Sciences, University of Bristol, Bristol, U.K. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Diabetes UK, University of Bristol, JDRF.
Abstract (Originalsprache)
Autoantibodies to glutamate decarboxylase (GADA) are widely used in the prediction and classification of type 1 diabetes. GADA radiobinding assays (RBAs) using N-terminally truncated antigens offer improved specificity, but radioisotopes limit the high-throughput potential for population screening. Luciferase-based immunoprecipitation system (LIPS) assays are sensitive and specific alternatives to RBAs with the potential to improve risk stratification. The performance of assays using the Nanoluc luciferase (Nluc)-conjugated GAD65 constructs, Nluc-GAD65(96–585) and full length Nluc-GAD65(1–585), were evaluated in 434 well-characterized serum samples from patients with recent-onset type 1 diabetes and first-degree relatives. Nonradioactive, high-throughput LIPS assays are quicker and require less serum than RBAs. Of 171 relatives previously tested single autoantibody positive for autoantibodies to full-length GAD65 by RBA but had not progressed to diabetes, fewer retested positive by LIPS using either truncated (n = 72) or full-length (n = 111) antigen. The Nluc-GAD65(96–585) truncation demonstrated the highest specificity in LIPS assays overall, but in contrast to RBA, N-terminus truncations did not result in a significant increase in disease-specificity compared with the full-length antigen. This suggests that binding of nonspecific antibodies is affected by the conformational changes resulting from addition of the Nluc antigen. Nluc-GAD65(96–585) LIPS assays offer low-blood-volume, high-specificity GADA tests for screening and diagnostics. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Diabetes and Metabolism Unit, Translational Health Sciences, University of Bristol, Bristol, U.K.
- San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- School of Biochemistry, University of Bristol, Bristol, U.K.
- Institute of Diabetes Research, Helmholtz Munich, German Center for Environmental Health, Munich, Germany.
- Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Forschergruppe Diabetes, Munich, Germany.
- Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ORCID-Profile: Sian L Grace, Lorenzo Piemonti, Anna E Long, Kathleen M Gillespie
Förderung
- Diabetes UK
- University of Bristol
- JDRF
Zitieren
APA
Wyatt, R. C., Grace, S. L., Brigatti, C., Marzinotto, I., Gillard, B. T., Shoemark, D. K., Chandler, K., Achenbach, P., Piemonti, L., Long, A. E., Gillespie, K. M., Lampasona, V., Williams, A. J. K., & BOX Study Group (2024). Improved Specificity of Glutamate Decarboxylase 65 Autoantibody Measurement Using Luciferase-Based Immunoprecipitation System Assays. Diabetes, 73(4), 565-571. https://doi.org/10.2337/db23-0550
Vancouver
Wyatt RC, Grace SL, Brigatti C, Marzinotto I, Gillard BT, Shoemark DK, et al. Improved Specificity of Glutamate Decarboxylase 65 Autoantibody Measurement Using Luciferase-Based Immunoprecipitation System Assays. Diabetes. 2024;73(4):565-571. doi:10.2337/db23-0550
BibTeX
@article{Wyatt2024,
author = {Wyatt, Rebecca C and Grace, Sian L and Brigatti, Cristina and Marzinotto, Ilaria and Gillard, Ben T and Shoemark, Deborah K and Chandler, Kyla and Achenbach, Peter and Piemonti, Lorenzo and Long, Anna E and Gillespie, Kathleen M and Lampasona, Vito and Williams, Alistair J K and BOX Study Group, BOX Study Group},
title = {Improved Specificity of Glutamate Decarboxylase 65 Autoantibody Measurement Using Luciferase-Based Immunoprecipitation System Assays},
journal = {Diabetes},
year = {2024},
volume = {73},
number = {4},
pages = {565--571},
doi = {10.2337/db23-0550}
}
EUVIMED